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Thematic Article
Consensus
In 2001 it is apparent that great shifts have occurred in the 
disease patterns in the Asia–Pacific region compared with
20–30 years before. The profound and overwhelming prob-
lems of protein energy malnutrition (PEM); infectious 
diseases, especially respiratory and gastrointestinal, viral,
bacterial and parasitic-like malaria; and food-borne illnesses
have given way to the so-called chronic non-communicable
diseases (CNCD) such as obesity, diabetes, cardiovascular
disease (CVD), certain cancers characteristic of western soci-
eties and osteoporosis. At the same time, however, new infec-
tions, including HIV-AIDS have appeared and tuberculosis
has become rife again. Antimalarial drug resistance is more
problematic. Micronutrient problems such as iron deficiency,
possibly folic acid and even, in some places, thiamin and vit-
amin A deficiency are persistent. Although iodine deficiency
is progressively coming under control, its reappearance in
Australian cities is disturbing and has raised new questions
about the food supply and contemporary food habits.
Atherosclerotic vascular disease is the greatest potential
regional health problem in the coming decade of the 21st
century, along with growing global concern about mental
health and depression in particular.1 Underpinning this new
health scenario are the lifestyle problems of lack of
employment opportunities and job satisfaction, sedentari-
ness, tobacco smoking, changing food patterns and an over-
all demographic change towards smaller families, ageing 
societies and urbanisation.
This analysis may, however, be too negative because
changes in lifestyle are associated with greater longevity and
healthier lives. For example, Japanese and citizens of Hong
Kong are located in the top league of life expectancies at
birth in the world. Based on the WHO disability adjusted for
life expectancies scales (DALES) Japan was rated number
one and Australia was number two.1–3
Several paradoxes about lifestyle and health have required
a review of the evidence and caution about the ready and
uncritical transfer of ‘solutions’ for the macrovascular dis-
ease epidemic from the west to the east.4
From 26th to 29th November, 2000 a group of food and
nutrition scientists and health care professionals, with a spe-
cial interest in cardiovascular disease within the Asia–Pacific
Region, gathered in Naha, Okinawa, Japan, the seat of the
former kingdom of the Ryukus. The Ryukus acquired much
culture and tradition from China over a period extending
back at least several hundred years. However, they were also
a trading kingdom with close links to Japan, South-east Asia,
especially what is now known as Indonesia and Malaysia,
and The Pacific. For these reasons, what might have been a
fairly typical island food culture, developed into a diversified
cuisine with characterising food and beverages, often based
on imported ingredients, novel food processing and prepara-
tive methods. The Ryukus have also been exposed for a long
time to ideas from abroad and it is a logical meeting place in
which to establish consensus. In this setting Okinawans have
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maintained low rates of CVD and achieved the longest 
documented life expectancy among Japanese nationals and
in the world. Thus, the Okinawan Consensus Conference on
Nutrition and Cardiovascular Disease in the Asia–Pacific
Region was held in November 2000.
Okinawa – community success rates as knowledge and
evidence
Initially, any proposals about preferred or optimal eating 
patterns for health must be operationally sound. Okinawa
provides an appropriate case study setting for food–health
relationships, especially in relation to CVD.5 The Okinawan
food culture has a number of distinguishing features, some of
these features are in common with other cultures. At present,
exceptionally good health statistics are available from this
food culture – for perinatal maternal, child health, anthropo-
metric and metabolic indices of nutritional status, patterns 
of CVD, cancer, bone health, mental health and longevity.
The complexity and transferability of these relationships is
another matter. However, the fact that environmental factors
exceed genetic make-up in this picture is now evident
through observations of migrant Okinawans in Hawaii and
Brazil. In Brazil, the health profile may be less than good,
but restituted, in part, through food interventions.6 Even
here, however, the interdependence of food intake, food
beliefs and social structure among Okinawans is not denied.7
What is clear is that the knowledge of Okinawan history,
culture, lifestyle (including food beliefs) and health statis-
tics, when subject to psychosocial and biomedical analysis,
provides important evidence about food–health relationships.
Much of this evidence will not be obtainable or deducible in
any other way. It will provide the basis for much more 
cohesive and durable health polices than can otherwise be
achieved.
Models and hypotheses
One of the most important ways of testing hypotheses is to
develop or define a model system to predict a required out-
come and then consider whether, over a nominated time
frame, the outcome was achieved. Predictive power which is
operational in this way, and then reproducible, is probably
the most usual way in which human knowledge advances.
Although not usually described as hypothesis testing, it is
careful observation and innovative perturbation of a system,
which have almost certainly been at the basis of much tradi-
tional practice. For example, careful observation of the ways
in which the food system changes and the effects of these
changes on health, has probably been at the heart of tradi-
tional food medicinals. When, however, not all the inputs are
defined and the system translocated, or when erroneous
deductions are made from observations, unhelpful belief 
systems emerge. 
There is great potential for the definition and measure-
ment of health food connection such as the diversity of the
scarce foods. The utility of these scores to predict health out-
comes may be tested over a given time frame. This has been
done in the Food Habits in Later Life (FHILL) studies of the
IUNS.8 This study has demonstrated that a score of the
Greekness of certain diets can predict survival.9 This can also
be done for foods which characterise particular cultures such
as soy (tofu, tempe, natto), fish and green tea for Japanese
and Okinawan cultures, especially where there are biomark-
ers (isoflavones, taurine and catechins, respectively).
It is worth noting that health sciences are unusual among
the sciences and technologies, in that they underestimate the
value of observational evidence in contrast to their expecta-
tion of randomised double-blind clinical trials. Recent papers
in The New England Journal of Medicine demonstrate that it
is the quality of the evidence, rather than the kind of evi-
dence, which is important in drawing conclusions.10 This is
a liberating view as only a small fraction of knowledge in the
health sciences is amenable to double-blind clinical trials.
The trials are usually restricted to a narrow range of vari-
ables, with limited application, unless the variable is critical
and uniting. This may be the case where there is a definable
inherited disorder of metabolism attributable to a single 
specific mutation (e.g., the LDL receptor defect).
The strengths and weaknesses of clinical nutrition trials
Clinical nutrition trials can test a particular intervention
(food constituents, food fortification or formulated foods) in
a randomised, placebo-controlled trial double-blind (RPCDB)
fashion. These types of trials are regarded by some agencies
as the ‘best’ kind of evidence.11–13 However, this can mean
that the evidence will never be available or, if it is, it may be
of poor quality because of the inherent difficulty of blinding
subjects. There are strengths and weaknesses of clinical
nutrition trials of the RPCDB kind (Table 1).
Table 1. Clinical nutrition trials – strengths and weaknesses
Type of test Strength Weakness
Randomised Locates evaluation to a Difficult to manage more than a few variables in the study.
limited number of variables. Complex systems not amenable to randomisation.
Placebo-controlled Measures effect over and Suitable placebo may not be available.
above background. Placebo effects may be of greater interest – potential benefit than 
intervention.
Not easy to design for synergistic effects.
Double-blind Reduces bias. Ethical constraints depending on nature of benefits; cannot test 
adverse effects.
Duration limited.
Cannot be used with basic food commodities and recipes difficult 
to blind.
Wahlqvist ML, Lukito W and Worsley A74
The aggregate of the strengths is that the findings can be
viewed with considerable confidence. However, the inherent
weaknesses reason that it is often difficult to extrapolate the
findings, to have a reliable estimate of unintended conse-
quences or to understand the impediments to implementation
or sustainability.
It is important to consider alternative experimental and
quasi-experimental designs which are used in behavioural
and social inquiry, education and evaluation research.14,15
Understanding mechanisms: experimental studies
The nature of western science is to find and understand 
the mechanisms whereby events occur, not only because it
increases certainty, but also allows the hypothesis to become
more acceptable. Thus, evidence obtained from observational
studies (hypothesis-modelling) and intervention trials (such
as placebo-controlled double-blind clinical nutrition trials) is
further established by complementary experiments in vitro, in
vivo in animals or, less commonly, in vivo in humans.
The corollary is that observational studies and clinical 
trials do not need to stand alone to support a conclusion or
recommendation.
Evaluating the health context
One of the most important challenges for the evaluation of
particular domains of evidence about health, such as food, is
how they relate to other domains of evidence. These include
social factors (education and human behaviours), along with
genetic, lifestyle, medicinal and the health care system itself
domains.
It is easy to underestimate the synergies between food
consumption and other behaviours or activities. For example,
a plant-based diet in its entirety can lower blood pressure
(BP) more effectively than say one plant food alone.16 Food
variety and dairy foods are even more effective in lowering
blood pressure.17 The combination of bodyfat reduction and
fish consumption is particularly impressive in lowering
blood pressure.18 In the same vein, Trichopolou has observed
that the Greeks’ diet contribution to survival is greater than
the sum of its parts.9
Food consumption is part of a general lifestyle. Healthy
food consumption habits may be more tolerable if one is 
regularly physically active and can eat more without putting
on bodyfat.19 This underscores the importance of gathering
evidence about a range of health determinants as one pursues
the role of food constituents, food and food patterns for CVD.
In the case of Okinawans, the importance of a comprehensive
biomedical, psychosocial and spiritual model of CVD risk and
longevity has been well documented.20 The present consensus
acknowledges this and encourages a broad appreciation of it.
Cost–benefit considerations
Evidence about nutrition and CVD inevitably raises ques-
tions not only about the relative merits of preventive and
management strategies, but also about their cost-effectiveness.
This economic information is increasingly built into evidence-
based decisions. For the Asia–Pacific region, pharmaceutical
approaches to disease prevention (e.g. blood pressure, lipid
and glycaemic control) may overwhelm individual and national
budgets. The annual cost of some drug regimens exceeds, by
far, the annual income of many who may need them. While
food can also be costly, a safe, secure and nutritious food
supply need not be unaffordable.
Nevertheless, this consensus acknowledges that there is
much work to be done on the relative economics of preven-
tive and therapeutic health approaches especially in the fields
of nutrition economics and pharmo-ecomonics.
Food-based approaches to health and CVD
In 1995 in Cyprus, WHO and FAO jointly developed Food
Based Dietary Guidelines (FBDG) to encourage culturally
sensitive, affordable and sustainable approaches to sound
nutrition and health. These were further developed by WHO
for the Western Pacific and published in 1999.21 Several
nations in the Asia–Pacific region have adopted FBDG.
Progress has also been made with FBDG for older individ-
uals.22 The opportunity now exists to render them relevant
for disease prevention. Underlying the present consensus
conference in Okinawa is the consideration that there can be
FBDG to reduce the burden of CVD in the Asia–Pacific
region. Indeed, Western Pacific FBDG have been incor-
porated into the WHO report on CNCD.23
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